Folic acid conjugated cross-linked acrylic polymer (FA-CLAP) hydrogel for site specific delivery of hydrophobic drugs to cancer cells by Jisha Pillai et al.
Pillai et al. Journal of Nanobiotechnology 2014, 12:25
http://www.jnanobiotechnology.com/content/12/1/25RESEARCH Open AccessFolic acid conjugated cross-linked acrylic polymer
(FA-CLAP) hydrogel for site specific delivery of
hydrophobic drugs to cancer cells
Jisha Jayadevan Pillai1, Arun Kumar Theralikattu Thulasidasan2, Ruby John Anto2, Devika Nandan Chithralekha1,
Ashwanikumar Narayanan1 and Gopalakrishnapillai Sankaramangalam Vinod Kumar1*Abstract
Background: The hydrogel based system is found to be rarely reported for the delivery of hydrophobic drug due
to the incompatibility of hydrophilicity of the polymer network and the hydrophobicity of drug. This problem can
be solved by preparing semi-interpenetrating network of cross-linked polymer for tuning the hydrophilicity so as to
entrap the hydrophobic drugs. The current study is to develop a folic acid conjugated cross-linked pH sensitive,
biocompatible polymeric hydrogel to achieve a site specific drug delivery. For that, we have synthesized a folic
acid conjugated PEG cross-linked acrylic polymer (FA-CLAP) hydrogel and investigated its loading and release of
curcumin. The formed polymer hydrogel was then conjugated with folic acid for the site specific delivery of curcumin
to cancer cells and then further characterized and conducted the cell uptake and cytotoxicity studies on human
cervical cancer cell lines (HeLa).
Results: In this study, we synthesized folic acid conjugated cross-linked acrylic hydrogel for the delivery of
hydrophobic drugs to the cancer site. Poly (ethyleneglycol) (PEG) diacrylate cross-linked acrylic polymer (PAA)
was prepared via inverse emulsion polymerization technique and later conjugated it with folic acid (FA-CLAP).
Hydrophobic drug curcumin is entrapped into it and investigated the entrapment efficiency. Characterization of
synthesized hydogel was done by using Fourier Transform-Infrared spectroscopy (FT-IR), Transmission Electron
Microscopy (TEM), Differential Scanning Calorimetry (DSC). Polymerization and folate conjugation was confirmed
by FT-IR spectroscopy. The release kinetics of drug from the entrapped form was studied which showed initial
burst release followed by sustained release due to swelling and increased cross-linking. In vitro cytotoxicity and
cell uptake studies were conducted in human cervical cancer (HeLa) cell lines.
Conclusions: Results showed that curcumin entrapped folate conjugated cross-linked acrylic polymer (FA-CLAP)
hydrogel showed higher cellular uptake than the non folate conjugated form. So this can be suggested as a better
delivery system for site specific release of hydrophobic cancer drugs.Background
Hydrogels are polymeric networks having three-dimensional
configuration capable of imbibing high amounts of water or
biological fluids. Their water absorbing property is mainly
attributed to the presence of hydrophilic groups such as –
OH, −CONH–, −CONH2–, and –SO3H in the polymers.
Due to the contribution of these groups and domains in the* Correspondence: gsvinod@rgcb.res.in
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unless otherwise stated.network, the polymer is thus hydrated to different degrees,
depending on the aqueous environment and polymer com-
position [1]. These ionizable functional groups present in it
affect its permeability mechanical stability and biocompati-
bility to a greater extends [2]. Along with that these struc-
tures have some common physical properties resembling
that of the living tissues, which is attributed to their high
water content, soft and rubbery consistency, and low inter-
facial tension with water or biological fluids [3-5]. The high
water content make it soft and wet just like a biological ma-
terial mimicking the extracellular matrix similar to macro-
molecular based compound in the human body [6,7].d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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system were the gel swell resulting in release of drug from
the polymer in a controlled manner. As water penetrate
through the polymer chain the glass temperature of the
polymer decreases and make the hydrogel rubbery [8].
These hydrogels have highly porous structure which helps
incorporation of drug into it. The high water content and
high porosity help them easy release of the drug within cer-
tain hours to days. The porosity of hydrogel can be tuned to
the required size of the drug by the addition of cross linker
to it. And thus it help in the controlled release of drug
[9,10]. The polymer used for the preparation of hydrogel is
of natural, synthetic and semi-synthetic origin. Even though
natural polymers have good bioactive properties [11] they
are found to have low mechanical strength so we make use
of synthetic polymers because of their good mechanical
strength and well-defined structure which can be modified
to improve the biocompatibility and biodegradability [12,13].
Polyacrylic acid based polymers are one of such ideal
candidates for the synthesis of hydrogel system for the
controlled drug delivery because of the swelling behavior
in aqueous environment [14]. It is a type of pH sensitive
polymer [15,16] which shows swelling at higher pH due
to the presence of ionizable carboxyl groups in it and
can release the drug at neutral pH. The main drawback
associated with PAA based drug delivery system is rapid
release of drug from it which can be controlled by cross-
linking. The cross-linking helps in slow drug release due
to small mesh size which can be advantageous for con-
trolled drug delivery applications. Cross-linking also im-
proves the physical properties of the hydrogel including
mechanical strength, degradability and diffusivity of
drugs from the system. The solubility of polymer in the
aqueous environment can also be prevented using cross-
linking [17,18].
Curcumin, a naturally occurring yellow coloured poly-
phenol obtained from the rhizome of the perennial herb
Curcuma longa, is found to have potent anticancer
properties [19]. It inhibit proliferation and induces apop-
tosis in various cancer cell lines isolated from malignan-
cies like leukemia, breast, lung, prostate and colon tumors
[20-23]. Studies were also done in various tumerogenetic
models [24-29] and some clinical trials were also done in
patients which confirmed the potential of curcumin as a
tool for cancer therapy. But its clinical application be-
comes limited due to poor water solubility, minimal sys-
temic bioavailability, degradation in alkaline pH and photo
degradation. So the therapeutic efficacy of curcumin can
be increased by incorporating curcumin in a biocompat-
ible polymer which enhances the solubility in aqueous so-
lution and extends the release.
One of the main problems associated with cancer ther-
apy is its unwanted side effect towards normal cells
along with the cancer cells. An active targeting strategycan improve the therapeutic efficacy of drugs and re-
duces the side effects [30-34]. For that we have to mod-
ify the polymer nanoparticles with certain ligands that
have its specific receptor on cancer cell surface. Folate
receptor has been extensively investigated for targeting
various tumor cells since it is normally expressed in vari-
ous types of cancer cells [35-38]. So the cross-linked
polymeric hydrogel nanoparticles which were structur-
ally modified with folic acid can help in easy targeting
and up taking of drugs by the cancer cells.
The hydrogel based system is found to be rarely re-
ported for the delivery of hydrophobic drug due to the
incompatibility of hydrophilicity of the polymer network
and the hydrophobicity of drug. This problem can be
solved by preparing semi-interpenetrating network of
cross-linked polymer for tuning the hydrophilicity so as
to entrap the hydrophobic drugs. The current study is to
develop a folic acid conjugated cross-linked pH sensitive
biocompatible polymeric hydrogel to achieve a site spe-
cific drug delivery. For that, we have synthesized a folic
acid conjugated PEG cross-linked acrylic polymer (FA-
CLAP) hydrogel and investigated its loading and re-
lease of curcumin. Here we used inverse emulsion
polymerization technique proposed by Vanderhoff et al.
for the polymerization of acrylic acid where an aqueous
solution of hydrophilic monomer acrylic acid is dispersed
in a continuous lipophilic phase with the aid of surfactants
to promote the formation of water in oil (W/O) emulsion
[39]. The formed polymer hydrogel was then conjugated
with folic acid for the site specific delivery of curcumin to
cancer cells and then further characterized and conducted
the cell uptake and cytotoxicity studies on human cervical
cancer cell lines (HeLa).
Results and discussion
Synthesis and characterization of FA-CLAP hydrogel
Curcumin loaded folic acid conjugated cross-linked
acrylic polymer (FA-CLAP) hydrogel were synthesized
successfully using inverse emulsion polymerization tech-
nique (Figure 1). Inverse emulsion polymerization is a
controllable technique used for the preparation of well-
defined nanoparticles. In the present study, we prepared
acrylic polymer cross-linked with polyethylene glycol
diacrylate by inverse micro emulsion polymerization
method which is cross-linked with folic acid through
ethylenediamine for targeted delivery of curcumin to
cancer cells. Inverse polymerization helps in the easy fa-
cilitating of free radical polymerization of acrylic mono-
mer with PEG diacrylate in presence of ammonium
persulfate. PEG, a highly biocompatible and hydrophilic
polymer with low Tg and polyacrylic acid in the system
imparts pH sensitivity. The hydrogel that we prepared
displays pH sensitive nature which can be exploited for
site specific controlled drug delivery. Folic acid is also
Figure 1 Scheme of polymer synthesis. Schematic representation showing the synthesis of folate conjugated cross-linked acrylic
polymer hydrogel.
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delivery of the drug encapsulated hydrogel towards the
cancer cells since many cancer cells are expressing folic
acid on its surface and pH sensitivity helps in the swell-
ing of the hydrogel in the required site with the sus-
tained release of drug on that particular site. The
percentage swelling in a pH dependant manner was
analyzed and given in Additional file 1.Characterization
Morphology and the size of the particles were studied
using Transmission electron microscopy. The nanoparti-
cles obtained were of size range of 160–190 nm with nar-
row size distribution (Figure 2). The folic acid conjugated
cross-linked polymer hydrogel particle shows a round
morphology with nanometric size range. Particle size was
found to increase with folic acid conjugation in it.
Figure 2 Transmission electron microscope image of (FA-CLAP).
TEM image of prepared curcumin loaded FA-CLAP hydrogel nanoparticles.
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size should be needed for a drug delivery particle so that
it will not easily leak out of the capillaries and also not
easily up taken by the macrophages. Here also we devel-
oped a particle which is having a size of about 190 nm
that is optimal for the cellular uptake and the folic acid
conjugation will help in the active targeted delivery of
nanoparticle into the cancer site. Active targeting help in
faster accumulation of nanoparticles in the cancer site and
help in the release of drug to that particular site [12].
DSC was done to find the thermal behavior of the nano-
particles. DSC of folic acid conjugated cross-liked acrylic
polymer and curcumin loaded folic acid conjugated cross-
linked polymer were done as showed in Figure 3. Folic
acid conjugated polymer shows an endothermic peak at
115°C which after loading with curcumin showed a de-
crease in value (endothermic peak at 85°C) and the nano-
gel was found to be stable up to 200°C.Figure 3 Differential scanning calorimetry (DSC) of hydrogel.
DSC of samples (A) FA-CLAP hydrogel (B) Curcumin-entrapped
FA-CLAP hydrogel.The DSC of FA-CLAP hydrogel shows endothermic
transition peak at 115°C which can be due to the loss of
loose and bound water in the hydrogel [40]. The gel ap-
peared to be thermally stable up to 200°C. Curcumin
was loaded to the cross-linked acrylic polymer through
physical adsorption by post loading method. And the
DSC of curcumin loaded FA-CLAP hydrogel shows an
endothermic peak at 85°C. Cross-linking using PEG dia-
crylate provides hydrophobicity to the acrylic hydrogel
which enhances the uptake of curcumin, a hydrophobic
drug. Swelling of the polymer occurs at a pH above the pKa
of the carboxyl group of acrylic acid. Swelling increases with
COO- groups and decreases with increasing cross-links.
The cross-linking and folate conjugation was con-
firmed by FTIR spectroscopy. FTIR spectroscopy clearly
gives idea about cross-linking and conjugation of folic
acid into the polymer (Figure 4). FTIR of cross-linked PAA
with EDA (ethylenediamine) was shown in Figure 4(A) in
which the peak at 3428.7 cm−1 may be due to N-H stretch-
ing of free amino group in ethylenediamine and peak at
1633.6 cm−1and 1566.7 cm−1 may be of stretching of amide
bond І and II that is formed between ethylenediamine and
cross-linked PAA which indicates EDA conjugation with
the polymer. Peak at 2950.9 cm−1 may be due to aliphatic
C-H stretching of poly acrylate. FTIR of FA-CLAP hydro-
gel was shown in Figure 4(B) in which the absorption band
at 2929.6 cm−1 is due to asymmetric C-H stretching vibra-
tion of folic acid. In addition to this other peaks like
1485.3 cm−1 (−C = C- aromatic stretching of phenyl ring)
and 1411.8 cm−1 (OH deformation of phenyl skeleton)
confirm the presence of folic acid in FA-CLAP [41]. Peaks
at 1626.5 cm−1 and 1574.9 cm−1 are due to amide I andFigure 4 Fourier transform infra red spectra. FTIR of the
synthesized co polymer: (A) Polyacrylic acid with ethylenediamine
(B) FA-CLAP hydrogel.
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may be due to C = N medium stretching in the pteridine
ring of folic acid which all confirmed the folic acid conju-
gation with ethylenediamine conjugated cross-linked PAA.
It shows peak at 1717.7 cm−1 which may be due to the
presence of free COOH groups in the prepared polymer.
In-vitro drug release
Curcumin is found to be poorly soluble in water and it
form flakes in it. So it is incorporated in a cross-linked
polymer hydrogel for delivery to the cancer site. For mak-
ing targeting more specific, folate conjugation was also
done to it. This makes the release of the drug from hydro-
gel in a controlled manner by the swelling of the gel. En-
trapment efficiency of folic acid conjugated cross-linked
polymer was found to be 61.2 ± 1.2%. In vitro release pro-
file of entrapped drug curcumin from FA-CLAP was done
and is shown in (Figure 5). Here the polymer showed an
initial release of 10% within 2 hrs and 20-40% release with
in 24 hrs (Higuchi diffusion model [42]) because of swell-
ing of hydrogel and thereafter the release occur in slow
sustained manner which might be due to the decrease in
the swelling because of increased cross-linking. The release
was markedly noticeable from 120–200 hours were 50% of
the increase in drug release was observed. After 200 hours
almost 97% of the drug was released and a steady state was
observed. Due to the presence of folic acid, targeted release
of drug is possible. Controlled and targeted release of drug
from the cross-linked polymer is a desirable property for
most of drug delivery applications as it reduces the side ef-
fect and increases the bioavailability.
Cell uptake studies
Curcumin entrapped FA-CLAP show better cellular uptake
compared to free curcumin
We analyzed whether folic acid conjugation to PAA nano-
curcumin surface can improve the drug delivery to cancerFigure 5 In vitro release of curcumin. Release kinetics of curcumin
from FA-CLAP hydrogel.cells, since cancer cells over-express folate receptors. The
internalization of curcumin to the cells was visualized by
confocal microscopy and the results indicate that curcu-
min entrapped FA-CLAP hydrogel show better cell uptake
than free curcumin dissolved in DMSO (Figure 6).
MTT assay
Folic acid-conjugated PAA (FA-CLAP) nanocurcumin induce
cytotoxicity in HeLa cells
We compared the efficacy of folic acid-conjugated PAA
(FA-CLAP) nanocurcumin with its free counterpart in
inducing cell death of HeLa cells. HeLa cells were ex-
posed to free curcumin or folic acid-conjugated PAA
nanocurcumin (5–50 μM) for 72 h. The nanoformula-
tion imparts high cytotoxicity than free curcumin in
dose dependent manner especially for 15 μM, 25 μM
and 50 μM. The results indicate that the folic acid-
conjugated PAA nanocurcumin (FA-CLAP) show com-
paratively better efficacy in inducing cytotoxicity of
HeLa cells than free curcumin dissolved in DMSO
(Figure 7).
Acridine orange (AO)/ethidium bromide (EB) staining
Conjugation of Folic acid on PAA nanocurcumin slightly
enhance the apoptotic effect induced by the latter in HeLa
cells
Ability of curcumin in inducing apoptosis of HeLa cells
were assessed by AO/EB staining. HeLa cells were ex-
posed to free curcumin or folic acid-conjugated PAA
(FA-CLAP) nanocurcumin (25 μM) for 24 h. When
treated with AO/EB mixture the untreated cells showed
bright green chromatin due to AO staining. The dam-
aged membrane of the apoptotic cells allowed EB to get
in, giving red color to the nucleus. In Figure 8 we can
vividly observe more number of cells in the red colour
(6 out of 16 cells, ~40%) than blank curcumin (2 out of
10 cells, ~20%).The results indicate that conjugation of
folic acid on PAA nanocurcumin enhances its apoptotic
activity in HeLa cells compared to the free curcumin
dissolved in DMSO as assessed by increase in number of
EB stained cells (Figure 8).
Conclusions
Curcumin, which has many medicinal properties mainly,
lacks its activity due to its low water solubility. So
through this work the delivery of hydrophobic drug cur-
cumin is done by incorporating the drug into cross-
linked hydrogel matrix and the cell uptake which was
another problem was further enhanced by introducing
folic acid into the system. It was found that folic acid
conjugated cross-linked hydrogel polymer (FA-CLAP)
loaded with curcumin showed better cellular uptake
compared to the non-folate hydrogel particles. So this
Figure 6 Cellular uptake image. Cell uptake of folic acid-conjugated PAA (FA-CLAP) nanocurcumin and free curcumin: HeLa cells were treated
with curcumin formulations as mentioned in materials and methods and confocal images were taken in the FITC channel.
Figure 7 Cytotoxic effect of folic acid-conjugated PAA nano-
curcumin. HeLa cells were treated with folic acid-conjugated PAA
(FA-CLAP) nanocurcumin or curcumin in DMSO. Optical densities were
measured and relative cell viability was plotted.
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ery of hydrophobic drugs.Methods
Materials
Acrylic acid (Mw ~ 72), cross-linker poly (ethylene gly-
col) diacrylate (Mw ~ 238,), Curcumin, Ammonium
persulphate (APS), Span 80 (Sorbitan monooleate), Tween
80 (Poly (ethyleneglycol) sorbitan monooleate), 3-(4,5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide
(MTT), ethylenediamine and folic acid were purchased
from Sigma-Aldrich, Germany. Acridine orange and
ethidium bromide were purchased from Sigma Aldrich.
DMEM was purchased from Life Technologies (Grand
Island, NY, USA). MTT was purchased from Calbio-
chem, Germany and Propidium Iodide from Calbio-
chem, USA. All other reagents and chemicals were of
Figure 8 Fluorescence images of HeLa cells treated by free curcumin or folic acid-conjugated PAA (FA-CLAP) nanocurcumin showing
apoptosis. HeLa cells were treated with different curcumin formulations for 24 h and were stained with acridine orange and ethidium bromide
solutions as mentioned in materials and methods and fluorescence images were taken using an inverted fluorescent microscope.
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purification.
Preparation of folic acid conjugated cross-linked poly-
meric nanoparticles
Preparation of cross-linked acrylic polymer
The cross-linked acrylic polymer (1%) was prepared by
inverse emulsion polymerization technique. Emulsifica-
tion was done by dispersing aqueous phase consisting of
10% acrylic acid, 5% sodium hydroxide and 15% water
with continuous lipophilic phase consisting of liquid par-
affin (68%), emulsifiers (2%), Span 80 and Tween 80
(75:25 ratio). For cross-linking, 1% of PEG diacrylate
was added to the mixture followed by the addition of
initiator, ammonium persulfate (APS). The temperature
for polymerization was at 60°C for 6 hours. The cross-
linked polymeric particles were isolated by centrifuga-
tion (10,000 rpm) for 30 min. The isolated polymeric
particles were washed several times with hexane and
stored for further structural modifications.
Conjugation of folic acid to the prepared cross-linked poly-
meric particles (FA-CLAP)
For the conjugation of folic acid to the prepared cross-
linked polymeric particles, first the cross-linked poly-
meric particle (850 mg. 1.2 eq) has to be treated with
ethylenediamine (3.2 ml, 0.65 eq) through carbodiimide
chemistry for the availability of free amine group for the
binding of activated folic acid to it. Simultaneously folic
acid (220 mg, 0.5 eq) has to be ester activated then it is
allowed to react with ethylenediamine conjugated cross-
linked acrylic hydrogel. A measured amount of this
ethylenediamine conjugated cross-linked polymeric par-
ticles (550 mg) was dissolved in DMSO. The reaction
mixture is kept overnight stirring, for the completion of
folic acid conjugation; cross-linked polymeric particles
were isolated by centrifugation (10,000 rpm) for 30 min.
The isolated folic acid conjugated cross-linked polymeric
hydrogel (FA-CLAP) was washed several times and then
freeze dried to remove solvent and water. The freeze
dried product was stored in vacuum. The polymerizationof acrylic acid with PEG diacrylate cross-linking and
folic acid conjugation was characterized using DSC and
FT-IR spectroscopy. The amount of folic acid conjugated
was also estimated (see Additional file 1).Drug loading
Loading of curcumin in folic acid conjugated cross-
linked polymeric nanoparticles (FA-CLAP) was done by
post-polymerization method. 100 mg of the lyophilized
powder was dispersed in 10 mL distilled water. Curcu-
min was dissolved in chloroform and the drug solution
in chloroform was added to the polymeric solution with
constant vortexing and sonication. The curcumin loaded
FA-CLAP hydrogel was then lyophilized to obtain dried
powder.Characterization of prepared hydrogel nanoparticles
Morphological analysis of the free and curcumin loaded
FA-CLAP nanoparticles were then characterized using
transmission electron microscopy (TEM, JEOL 1011,
and Japan). The samples of the nanoparticle suspension
in water milli-Q at 25°C were dropped on to formvar-
coated grids and measurements were taken only after
the samples were completely dried.
Folic acid conjugation in the parent polymer was con-
firmed using FTIR spectroscopy. FTIR spectroscopy was
performed on a Spectrum 65 (Perkin Elmer). Spectra
were recorded between 4000 and 600 cm−1 wave num-
ber range. Dried samples were mixed with KBr and fur-
ther compressed in to pellets for making measurements.
Differential Scanning Calorimetry (DSC) was done to
analyze the thermal behavior of the FA-CLAP and Cur-
cumin loaded FA-CLAP hydrogel. DSC thermograms
obtained were then analyzed using an automatic thermal
analyzer system (Pyres 6 DSC, Perkin-Elmer, USA). Sam-
ples were placed in standard aluminum pans and heated
from 20 to 250°C at a rate of 10°C/minute under con-
stant purging of N2 at 10 mL/minute. An empty pan,
sealed in the same way as that of the sample, was used
as a reference.
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A known amount of the curcumin loaded folic acid con-
jugated cross-linked polymer (FA-CLAP) hydrogel nano-
particles were dissolved in methanol and vigorously
vortexed to get a clear solution and it is kept for
24 hours, and then filtered through 0.1 μM membrane
filter. The absorbance of the filtrate was then taken at
420 nm by using UV absorbance (Perkin Elmer, USA).
The entrapped amount of curcumin was then deter-
mined by actual entrapment ratio (AER), expressed in
terms of amount of curcumin per weight of nanoparti-
cles [43]. Entrapment efficiency can be calculated by the
equation
Entrapment Efficiency %ð Þ ¼ AER = TER  100
(AER = Measured drug wt/ Nanoparticle wt & TER =
Initial drug wt/ drug wt & polymer wt). Where (AER) is
Actual entrapment ratio and (TER) is Theoretical en-
trapment ratio. Nanogel wt means the weight of the
nanogel with curcumin taken for calculating entrapment
efficiency and Initial drug weight means drug initially
taken for the entrapment.
In vitro release kinetics
For in vitro release study, a known amount of curcumin
loaded FA-CLAP were dispersed in 10 mL of P.B.S
(pH 7.4) and was then left in a shaking incubator at 37
± 0.5°C. A known quantity of sample was then with-
drawn and replaced with fresh medium in a predeter-
mined time intervals for maintaining the total volume
constant. The amount of curcumin released from the
hydrogel nanoparticle was then measured using UV
spectrophotometer (Perkin Elmer, USA) at 420 nm.
Cell uptake studies
Cellular uptake of curcumin and folic acid-conjugated
PAA (FA-CLAP) nanocurcumin were studied using con-
focal microscopy. Briefly, 2.0 × 104 HeLa cells were grown
on cover slips placed in 24 well plates. After overnight in-
cubation, when the cells attained their morphology, they
were treated with curcumin dissolved in dimethyl sulfox-
ide (DMSO) (25 μM), folic acid-conjugated PAA nanocur-
cumin (25 μM) was suspended in aqueous medium and
blank polymer. After 2 h of incubation the cells were
washed with 1X PBS, fixed with PFA and the nuclei were
stained with propidium iodide and were mounted using
DPX. Cells were examined for intracellular fluorescence of
curcumin using confocal laser scanning microscope in the
FITC channel (488 nm).
MTT assay
Cytotoxicity studies of free curcumin and folic acid-
conjugated PAA nanocurcumin were carried out in HeLacells using MTT assay [44]. HeLa cells were seeded (3.0 ×
103/well) in a 96-well culture plate and grown for 24 h be-
fore the assay. The cells were then treated with different
concentrations of curcumin dissolved in DMSO and folic
acid-conjugated PAA nanocurcumin (5–50 μM) for 72 h
and then 20 μl MTT (5 mg/ml) was added in 80 μl culture
medium to each well. After incubating for 2 h at 37°C,
cells were lysed using lysis buffer, incubated for 1 h, and
the optical densities were measured at 570 nm using a mi-
croplate reader (Bio-Rad Laboratories, Hercules, CA). The
relative cell viability in percentage was calculated as:
Relative Cell Viability ¼ ðA570 of treated samples =
A570of untreated samplesÞ  100
Acridine orange (AO)/ethidium bromide (EB) staining
Acridine orange/ethidium bromide (AO/EB) double stain-
ing was used to detect apoptosis [45]. Briefly, 5 × 103 cells/
well were seeded in a 96-well plate and treated with curcu-
min in DMSO (25 μM) or folic acid-conjugated PAA
(FA-CLAP) nanocurcumin (25 μM) for 24 h. After
washing with 1X PBS, the cells were stained with acridine
orange (100 μg/ml) and ethidium bromide (100 μg/ml)
solutions for 2 min. The cells were then washed with
1X PBS, viewed under an inverted fluorescent micro-
scope (Nikon Eclipse, TE-300) and were photographed.
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